Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114654502 | 11465450 | 2 | F | 20160609 | 20150907 | 20160905 | PER | US-ASTRAZENECA-2015SE82046 | ASTRAZENECA | 0.00 | F | Y | 50.80000 | KG | 20160905 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114654502 | 11465450 | 1 | PS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG 1 PUFF TWICE A DAY | 202450 | INHALATION POWDER | |||||||||
| 114654502 | 11465450 | 2 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG 1 PUFF TWICE A DAY | 202450 | INHALATION POWDER | |||||||||
| 114654502 | 11465450 | 3 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG 1 PUFF TWICE A DAY | 1136132 | 202450 | INHALATION POWDER | ||||||||
| 114654502 | 11465450 | 4 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG 1 PUFF TWICE A DAY | 1136132 | 202450 | INHALATION POWDER | ||||||||
| 114654502 | 11465450 | 5 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG 2 PUFFS TWICE A DAY | 0 | BID | |||||||||
| 114654502 | 11465450 | 6 | C | ALBUTEROL WITH IPRATROPIUM BROMIDE | 2 | Respiratory (inhalation) | 25 MG AND 3 MG PER 3 ML THREE TIMES A DAY VIA NEBULIZER | 0 | |||||||||||
| 114654502 | 11465450 | 7 | C | METOPROLOL. | METOPROLOL | 1 | 0 | 25 | MG | BID | |||||||||
| 114654502 | 11465450 | 8 | C | ZOCOR | SIMVASTATIN | 1 | 0 | 40 | MG | QD | |||||||||
| 114654502 | 11465450 | 9 | C | MULTIVITAMINS | VITAMINS | 1 | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114654502 | 11465450 | 1 | Chronic obstructive pulmonary disease |
| 114654502 | 11465450 | 2 | Emphysema |
| 114654502 | 11465450 | 3 | Chronic obstructive pulmonary disease |
| 114654502 | 11465450 | 4 | Emphysema |
| 114654502 | 11465450 | 5 | Chronic obstructive pulmonary disease |
| 114654502 | 11465450 | 6 | Chronic obstructive pulmonary disease |
| 114654502 | 11465450 | 7 | Hypertension |
| 114654502 | 11465450 | 8 | Blood cholesterol abnormal |
| 114654502 | 11465450 | 9 | Supplementation therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114654502 | 11465450 | Lung disorder | |
| 114654502 | 11465450 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114654502 | 11465450 | 1 | 2013 | 0 | ||
| 114654502 | 11465450 | 2 | 2013 | 0 | ||
| 114654502 | 11465450 | 3 | 20150817 | 0 | ||
| 114654502 | 11465450 | 4 | 20150817 | 0 | ||
| 114654502 | 11465450 | 5 | 20150625 | 0 | ||
| 114654502 | 11465450 | 6 | 2013 | 0 |